HDL-ApoA1 is crucial for preventing atherosclerosis and heart diseases, but purifying it from blood plasma has been complicated and inefficient in the past.
A new two-step purification method was developed, utilizing ammonium sulfate precipitation followed by HEA HyperCel™ chromatography, which significantly improved the process.
The method resulted in a 63% yield of pure, monomeric ApoA1, making it a promising alternative for further biochemical and clinical research.